ADHD medication shortages: a continuity plan for adults in Idaho, Washington, Oregon, Arizona, and Utah

The ADHD medication shortage that began in October 2022 is still with us in 2026. Adderall and Adderall XR remain on the FDA Drug Shortage Database as of July 2026, along with methylphenidate ER (Concerta and generics) and generic lisdexamfetamine. The DEA raised 2026 production quotas — d,l-amphetamine to 24.2 million grams (~14% above the proposal) and lisdexamfetamine to 51.3 million grams (~22%) — but higher quotas do not translate instantly into pharmacy shelves (DEA 2026 APQ Final Order).

If you take a stimulant, you should expect intermittent supply issues in 2026 and plan for them. This post is the continuity playbook for adult patients in Idaho, Washington, Oregon, Arizona, and Utah.

Key Takeaways

• The shortage is patchy — some strengths and manufacturers are available, others aren't, and the picture shifts week to week.
• Do not stop or self-adjust your medication because of a shortage. Coordination with your prescriber and pharmacy is the plan.
• Call the pharmacy before you need the refill, not on the day you run out.
• Cross-state fills are legal within our footprint but require prescriber coordination and a re-issued prescription.
• Formulation switches (Adderall → Vyvanse, methylphenidate → amphetamine) are medical decisions, not pharmacy decisions.

What's actually in shortage right now

Status as of July 2026 (verify at the FDA shortage database before your refill):

Medication	Status	Notes
Adderall (mixed amphetamine salts IR)	In shortage	Generic IR hardest to find; specific strengths worse than others
Adderall XR	In shortage	10 mg and 20 mg XR particularly affected; resupply dates slip
Vyvanse (brand lisdexamfetamine)	Generally available	Generic lisdexamfetamine remains spotty
Methylphenidate ER (Concerta, Ritalin LA)	In shortage	Multiple manufacturers on backorder
Methylphenidate IR (Ritalin)	Intermittent	Varies by manufacturer
Focalin / Focalin XR (dexmethylphenidate)	Spot shortages	Strength-dependent
Non-stimulants (atomoxetine, guanfacine, viloxazine)	Available	Not affected

Higher DEA quotas in 2026 will help supply, but equilibrium is projected for late 2026 to 2027 at the earliest (Federal Register 2026 APQ Final Order).

The continuity plan

Six habits that keep your treatment stable through a supply-constrained year.

1. Call the pharmacy before you need the refill

Call 5–7 days before you'll run out. Ask two things: "Do you have my exact medication, dose, and strength in stock right now?" and "What is your estimated resupply date if you don't?" Do not wait until the day of.

2. Know your manufacturer and strength

Pharmacies substitute generics from different manufacturers without telling you. Some substitutions work fine; others cause a noticeable change in effect. If you find a generic that works well, note the manufacturer (Teva, SpecGx, Elite, Sandoz, etc.) and ask the pharmacy to request that specific one when possible.

3. Do not fill early to hoard

DEA rules and pharmacy insurance rules prohibit early fills. Attempting an early fill flags on the PDMP and creates a documentation problem that follows you. If your current prescription runs out during a shortage, we work with the pharmacy on a legitimate resupply — not a stockpile.

4. Do not skip doses to stretch supply

If you have 15 days of medication and 30 days until your next fill, do not take a half dose to stretch it. That produces inconsistent blood levels, weeks of poor executive function, and often anxiety and mood destabilization. If supply is genuinely at risk, message us — we adjust the plan clinically, not by rationing.

5. Do not switch pharmacies without a plan

Every pharmacy hop generates a new prescription transmission, a new PDMP entry, and a new opportunity for a stockout at the destination pharmacy. If you're switching pharmacies (moving, changing insurance, or because your current one is out), tell us first so we can send the prescription to the right place with correct details.

6. Message us early if you can't fill

If you've called three pharmacies and no one has your medication, message us through Spruce with:

• Medication and dose you're currently prescribed
• Pharmacies you've called and what each said
• How much medication you have left in days

We can (a) reissue to a pharmacy that has stock, (b) authorize a temporary formulation change to an available equivalent, or (c) discuss a short-term bridge with a different medication class. All of those require a plan, not a phone call at 5:00 PM on the day you run out.

What requires a visit vs. what a message can handle

Portal or Spruce message is enough for:

• Refill sent to a pharmacy that has your usual medication
• Reissue of the exact same prescription to a different pharmacy
• Question about whether a specific pharmacy has stock

Requires a video follow-up:

• Switching from one stimulant class to another (Adderall to Vyvanse, methylphenidate to amphetamine, or vice versa)
• Switching from a stimulant to a non-stimulant
• Dose changes
• Any change in response, side effects, or blood pressure since last visit

Formulation switches are not one-to-one. Adderall 20 mg XR is not equivalent to Vyvanse 40 mg. Concerta 36 mg is not the same as methylphenidate IR 10 mg three times a day. We convert with a plan, monitor the transition, and re-check at 2 weeks.

Cross-state considerations for our five states

The good news: I hold active licenses in Idaho, Washington, Oregon (also Nevada pending DEA and Arizona and Utah), and DEA registration in each. That means we can prescribe to a pharmacy in any of those states.

The nuance:

• Prescription must be sent to a pharmacy in the state you're physically located in at the time of the visit. You must be physically in one of my licensed states at the time of the appointment.
• First fill of a Schedule II cannot cross state lines at most mail-order pharmacies. If you're traveling and run out in another state where a walk-in pharmacy has your medication, we usually can send a same-state fill to that pharmacy — but only if you're physically located in one of my licensed states.
• Pharmacy-of-record changes require a new e-prescription. Cannot be "transferred" like a non-controlled substance.
• PDMP is checked at every controlled-substance visit across all five states. Duplicate prescribing from another provider will be visible.

Benefits and Limits of the plan

Benefits of coordinated shortage management:

• Prevents gaps in medication that trigger rebound symptoms and lost work time
• Avoids desperate pharmacy hopping that creates PDMP red flags
• Preserves the option of your usual medication when supply returns
• Documents a defensible pattern of care for controlled substance monitoring

Limits:

• No prescriber can conjure medication from an empty pharmacy shelf. Some weeks the answer is "nothing in stock anywhere within 25 miles."
• Formulation switches introduce a period of dose-finding all over again.
• Insurance step-therapy rules may require prior authorization for a switch, which adds 3–5 business days.

Risks, Side Effects, or When to Reach Out

Reach out through Spruce or the portal promptly if:

• You've been off medication for more than 3–4 days and are experiencing significant mood changes, work disruption, or driving concerns
• You experience side effects from a substituted generic (chest tightness, palpitations, marked anxiety, or unusual GI symptoms)
• Blood pressure at home is consistently above 140/90 on medication
• Any acute mental-health concern, especially suicidal thinking

Do not double-dose to compensate for a missed day. Do not take someone else's medication.

Idaho, Oregon, Washington, Arizona, and Utah Telehealth Notes

Our telehealth footprint in 2026 lets us handle shortage-driven changes over video for patients in ID, WA, OR, AZ, and UT. Nevada is pending DEA registration. The DEA Fourth Temporary Extension covering controlled-substance telehealth prescribing is in force through December 31, 2026 (see our post on the 2026 telehealth rules).

Practical points:

• Have your current pharmacy name, phone, and address handy at every visit
• Note any recent generic manufacturer changes on your bottle
• If you travel between our states regularly, tell us your usual pattern so we can plan pharmacy of record

Practical Next Step

If you are a current patient dealing with a fill problem right now: message through Spruce with the details from the "message us early if you can't fill" section above.

If you are a prospective patient and want continuity of care that includes shortage management: book an initial evaluation at brandon-kruse.clientsecure.me/request.

Other questions: office@embracepsychiatry.com.

Spruce Message Template

Subject: Pharmacy fill issue — need help

Hi — I take [medication, dose, strength]. My usual pharmacy is [name, city, state]. I'm having trouble filling my current prescription.

Pharmacies I've called:

• [Pharmacy 1] — [status: out of stock / partial / has it]
• [Pharmacy 2] — [status]
• [Pharmacy 3] — [status]

Medication remaining: [X days] State I'm physically in: [ID / WA / OR / AZ / UT]

What I've been told about resupply: [any dates given]

Please advise on next steps — reissue elsewhere, temporary formulation change, or other.

Thanks.